Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Yang

Showing results (171-180 of 185) with videos related to

Pageof 19
Sort By:
JACC. Cardiooncology|October 10, 2022
Impact of Social Vulnerability on Comorbid Cancer and Cardiovascular Disease Mortality in the United StatesSarju Ganatra, Sourbha S Dani, Ashish Kumar, et al.
Blood|January 29, 2021
CD22-directed CAR T-cell therapy induces complete remissions in CD19-directed CAR-refractory large B-cell lymphomaJohn H Baird, Matthew J Frank, Juliana Craig, et al.
Cell Chemical Biology|April 10, 2018
Dependence on the Pyrimidine Biosynthetic Enzyme DHODH Is a Synthetic Lethal Vulnerability in Mutant KRAS-Driven CancersMalvika Koundinya, Judith Sudhalter, Albane Courjaud, et al.
Bioanalysis|October 8, 2016
2016 White Paper on recent issues in bioanalysis: focus on biomarker assay validation (BAV) (Part 1 - small molecules, peptides and small molecule biomarkers by LCMS)Eric Yang, Jan Welink, Stephanie Cape, et al.
Bioanalysis|October 11, 2012
2012 white paper on recent issues in bioanalysis and alignment of multiple guidelinesBinodh DeSilva, Fabio Garofolo, Mario Rocci, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 17, 2024
NCCN Guidelines® Insights: Survivorship, Version 2.2024Tara Sanft, Andrew T Day, Mindy Goldman, et al.
Bioanalysis|November 18, 2017
2017 White Paper on recent issues in bioanalysis: aren't BMV guidance/guidelines 'Scientific'? (Part 1 - LCMS: small molecules, peptides and small molecule biomarkers)Jan Welink, Eric Yang, Nicola Hughes, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 7, 2023
NCCN Guidelines® Insights: Survivorship, Version 1.2023Tara Sanft, Andrew Day, Shannon Ansbaugh, et al.
Nature Communications|October 16, 2019
Evaluation of integrin αvβ<sub>6</sub> cystine knot PET tracers to detect cancer and idiopathic pulmonary fibrosisRichard H Kimura, Ling Wang, Bin Shen, et al.
Bioanalysis|January 20, 2021
2020 White Paper on Recent Issues in Bioanalysis: BMV of Hybrid Assays, Acoustic MS, HRMS, Data Integrity, Endogenous Compounds, Microsampling and Microbiome (<u>Part 1</u> - Recommendations on Industry/Regulators Consensus on BMV of Biotherapeutics by LCMS, Advanced Application in Hybrid Assays, Regulatory Challenges in Mass Spec, Innovation in Small Molecules, Peptides and Oligos)Hendrik Neubert, Stephen C Alley, Anita Lee, et al.
Pageof 19

Showing results (171-180 of 185) with videos related to

Sort By:
Pageof 19
JACC. Cardiooncology|October 10, 2022
Impact of Social Vulnerability on Comorbid Cancer and Cardiovascular Disease Mortality in the United StatesSarju Ganatra, Sourbha S Dani, Ashish Kumar, et al.
Blood|January 29, 2021
CD22-directed CAR T-cell therapy induces complete remissions in CD19-directed CAR-refractory large B-cell lymphomaJohn H Baird, Matthew J Frank, Juliana Craig, et al.
Cell Chemical Biology|April 10, 2018
Dependence on the Pyrimidine Biosynthetic Enzyme DHODH Is a Synthetic Lethal Vulnerability in Mutant KRAS-Driven CancersMalvika Koundinya, Judith Sudhalter, Albane Courjaud, et al.
Bioanalysis|October 8, 2016
2016 White Paper on recent issues in bioanalysis: focus on biomarker assay validation (BAV) (Part 1 - small molecules, peptides and small molecule biomarkers by LCMS)Eric Yang, Jan Welink, Stephanie Cape, et al.
Bioanalysis|October 11, 2012
2012 white paper on recent issues in bioanalysis and alignment of multiple guidelinesBinodh DeSilva, Fabio Garofolo, Mario Rocci, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 17, 2024
NCCN Guidelines® Insights: Survivorship, Version 2.2024Tara Sanft, Andrew T Day, Mindy Goldman, et al.
Bioanalysis|November 18, 2017
2017 White Paper on recent issues in bioanalysis: aren't BMV guidance/guidelines 'Scientific'? (Part 1 - LCMS: small molecules, peptides and small molecule biomarkers)Jan Welink, Eric Yang, Nicola Hughes, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 7, 2023
NCCN Guidelines® Insights: Survivorship, Version 1.2023Tara Sanft, Andrew Day, Shannon Ansbaugh, et al.
Nature Communications|October 16, 2019
Evaluation of integrin αvβ<sub>6</sub> cystine knot PET tracers to detect cancer and idiopathic pulmonary fibrosisRichard H Kimura, Ling Wang, Bin Shen, et al.
Bioanalysis|January 20, 2021
2020 White Paper on Recent Issues in Bioanalysis: BMV of Hybrid Assays, Acoustic MS, HRMS, Data Integrity, Endogenous Compounds, Microsampling and Microbiome (<u>Part 1</u> - Recommendations on Industry/Regulators Consensus on BMV of Biotherapeutics by LCMS, Advanced Application in Hybrid Assays, Regulatory Challenges in Mass Spec, Innovation in Small Molecules, Peptides and Oligos)Hendrik Neubert, Stephen C Alley, Anita Lee, et al.
Pageof 19